Itay&Beyond
Itay&Beyond is a pioneering biotechnology company revolutionizing neurological and psychiatric drug development through a unique platform that integrates patient-derived brain organoids with advanced AI analysis. Their platform provides functional electrophysiological readouts and predictive modeling to estimate drug efficacy more accurately than traditional animal models, addressing the high failure rate in clinical trials. Focused initially on autism spectrum disorders and expanding to other neuropsychiatric conditions, Itay&Beyond's technology enables early-stage drug efficacy prediction, study design optimization, and repurposing of approved drugs, aiming to accelerate drug discovery and improve patient outcomes globally.
Itay&Beyond
Itay&Beyond is a pioneering biotechnology company revolutionizing neurological and psychiatric drug development through a unique platform that integrates patient-derived brain organoids with advanced AI analysis. Their platform provides functional electrophysiological readouts and predictive modeling to estimate drug efficacy more accurately than traditional animal models, addressing the high failure rate in clinical trials. Focused initially on autism spectrum disorders and expanding to other neuropsychiatric conditions, Itay&Beyond's technology enables early-stage drug efficacy prediction, study design optimization, and repurposing of approved drugs, aiming to accelerate drug discovery and improve patient outcomes globally.